Page results
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
File results
-
Patient diagnosis, referral, treatment for Essential Tremor/Deep Brain Stimulation/MR-guided Focused Ultrasound (MRgFUS)
-
-
-
-
-
-
-
-
Issue 19 - UCLH Magazine 2023
-